摘要
The tumor microenvironment (TME), which is mostly composed of tumor cells, immune cells, signaling molecules, stromal tissue, and the vascular system, is an integrated system that is conducive to the formation of tumors. TME heterogeneity makes the response to immunotherapy different in different tumors, such as "immune-cold" and "immune-hot" tumors. Tumor-associated macrophages, myeloid-derived suppressor cells, and regulatory T cells are the major suppressive immune cells and their different phenotypes interact and influence cancer cells by secreting different signaling factors, thus playing a key role in the formation of the TME as well as in the initiation, growth, and metastasis of cancer cells. Nanotechnology development has facilitated overcoming the obstacles that limit the further development of conventional immunotherapy, such as toxic side effects and lack of targeting. In this review, we focus on the role of three major suppressive immune cells in the TME as well as in tumor development, clinical trials of different drugs targeting immune cells, and different attempts to combine drugs with nanomaterials. The aim is to reveal the relationship between immunotherapy, immunosuppressive TME and nanomedicine, thus laying the foundation for further development of immunotherapy.
学科与关键词
- Polymeric Materials for the Regulation of Tumor Immune MicroenvironmentMiao, Wei-min; Wu, Jia-si; Tong, Qi-song; Huang, Yong-cong; Du, Jin-zhi*ACTA POLYMERICA SINICA, 2020, 51(5): 548-558.被引 4
- Targeting the tumor microenvironment to enhance antitumor immune responsesVan der Jeught Kevin; Bialkowski Lukasz; Daszkiewicz Lidia; Broos Katrijn; Goyvaerts Cleo; Renmans Dries; Van Lint Sandra; Heirman Carlo; Thielemans Kris; Breckpot KarineONCOTARGET, 2015, 6(3): 1359-1381.
- 纳米制剂在重塑肿瘤微环境和增强免疫疗效中的研究进展陈少伟; 应苗法; 顾胜龙; 赵蕊; 李明星中国药学杂志, 2020, 55(2): 85-89.
